Endocrinology, Diabetes & Metabolism Case Reports (Mar 2019)

Cushing syndrome: uncovering Carney complex due to novel PRKAR1A mutation

  • Catherine D Zhang,
  • Pavel N Pichurin,
  • Aleh Bobr,
  • Melanie L Lyden,
  • William F Young,
  • Irina Bancos

DOI
https://doi.org/10.1530/EDM-18-0150
Journal volume & issue
Vol. 1, no. 1
pp. 1 – 5

Abstract

Read online

Carney complex (CNC) is a rare multiple neoplasia syndrome characterized by spotty pigmentation of the skin and mucosa in association with various non-endocrine and endocrine tumors, including primary pigmented nodular adrenocortical disease (PPNAD). A 20-year-old woman was referred for suspected Cushing syndrome. She had signs of cortisol excess as well as skin lentigines on physical examination. Biochemical investigation was suggestive of corticotropin (ACTH)-independent Cushing syndrome. Unenhanced computed tomography scan of the abdomen did not reveal an obvious adrenal mass. She subsequently underwent bilateral laparoscopic adrenalectomy, and histopathology was consistent with PPNAD. Genetic testing revealed a novel frameshift pathogenic variant c.488delC/p.Thr163MetfsX2 (ClinVar Variation ID: 424516) in the PRKAR1A gene, consistent with clinical suspicion for CNC. Evaluation for other clinical features of the complex was unrevealing. We present a case of PPNAD-associated Cushing syndrome leading to the diagnosis of CNC due to a novel PRKAR1A pathogenic variant.